MiMedx Group Inc (MDXG) Shares are Down -1.96%

MiMedx Group Inc (MDXG) : During the past 4 weeks, traders have been relatively bearish on MiMedx Group Inc (MDXG), hence the stock is down -6.84% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.01% relative to the S&P 500. The 4-week change in the price of the stock is -5.88% and the stock has fallen -1.96% in the past 1 week.

The stock has recorded a 20-day Moving Average of 1.39% and the 50-Day Moving Average is 3.44%. MiMedx Group Inc (NASDAQ:MDXG): stock turned positive on Friday. Though the stock opened at $7.4, the bulls momentum made the stock top out at $7.55 level for the day. The stock recorded a low of $7.35 and closed the trading day at $7.52, in the green by 1.90%. The total traded volume for the day was 516,441. The stock had closed at $7.38 in the previous days trading.


The company Insiders own 12.3% of MiMedx Group Inc shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -8.35% . Institutional Investors own 42.74% of MiMedx Group Inc shares. During last six month period, the net percent change held by insiders has seen a change of 1.57%.

MiMedx Group, Inc. (MiMedx) is an integrated developer, manufacturer and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane. The Companys biomaterial platform technologies include AmnioFix and EpiFix, its tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through its donor program, mothers delivering full-term Cesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. MiMedx processes the human amniotic membrane utilizing its Purion Process to produce an implant, which is referred as an allograft. MiMedx is the supplier of amniotic tissue, having supplied over 350,000 allografts for application in the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental sectors of healthcare. Its CollaFix technology combines a means of creating fibers from soluble collagen and a cross-linking process.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.